CMS Plan Benefit Package (PBP) and Formulary CY 2027 (CMS-R-262) - IRA

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
43667	CY2027 Plan Benefit Package (PBP) Software and Formulary Submission Form and Instruction	Modified

ICR Details

OMB Control No: 0938-0763	ICR Reference No: 202603-0938-012
Status: Received in OIRA	Previous ICR Reference No: 202503-0938-003
Agency/Subagency: HHS/CMS	Agency Tracking No: CM-CPC
Title: CMS Plan Benefit Package (PBP) and Formulary CY 2027 (CMS-R-262) - IRA
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 03/25/2026

	Requested	Previously Approved
Expiration Date	36 Months From Approved	03/31/2027
Responses	8,068	8,337
Time Burden (Hours)	44,178	46,026
Cost Burden (Dollars)	0	0

---

Abstract: CMS has incorporated the following changes to address the Inflation Reduction Act (IRA). This includes new attestations and data entry fields to reflect Part D policy changes (i.e., new insulin and vaccine benefits and $0 cost sharing in the catastrophic phase) that are required by the IRA, specifically Sections 11101, 11201, 11401, and 11406. CMS is also modernizing the PBP software by migrating from its current client/server based platform to a new web-based module within HPMS. This initiative is critical, as the current platform technically antiquated. The new PBP module will enhance system security, improve the user interface, streamline the bid submission process, increase system performance, and provide greater flexibility to accommodate unique benefit designs. CMS requires that MA and PDP organizations submit a completed formulary and PBP as part of the annual bidding process. During this process, organizations prepare their proposed plan benefit packages for the upcoming contract year and submit them to CMS for review and approval.

---

Authorizing Statute(s): PL: Pub.L. 117 - 169 11101,11201, 11401, and 11406 Name of Law: Inflation Reduction Act
   PL: Pub.L. 108 - 173 101 Name of Law: Prescription Drug, Improvement, and Modernization Act of2003 (MMA)
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 36058	12/22/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	91 FR 14563	03/25/2026
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
CY2027 Plan Benefit Package (PBP) Software and Formulary Submission	CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262, CMS-R-262	MTM2027 Mockup ,   Benefit Details-Service Categories 1-10 ,   Benefit Details-Service Categories 11-15 ,   Cost Share Groups ,   General Setup ,   Section Rx ,   VBID Rx ,   VBID-UF-SSBCI Packages ,   CY 2027 Prior Authorization File Record Layout ,   CY 2027 Step Therapy File Record Layout ,   Benefit Details - Service Categories 16-20

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	8,068	8,337	0	-269	0	0
Annual Time Burden (Hours)	44,178	46,026	0	-1,848	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: The decrease in burden is attributable to a decrease in the number of reporting organizations from 785 to 764, as well as a decrease in the number of formulary submissions from 484 to 427 and estimated reduction in burden hours for completing the formulary submissions. This decrease in respondents and time per response has decreased the overall total burden from 46,026 to 44,178 hours.

---

Annual Cost to Federal Government: $2,418,182

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Yes

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/25/2026

---

Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.